# AMPICILLIN AND SULBACTAM
> **ANDA065310** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2006-07-25
## Drug
- **FDA Application Number:** ANDA065310
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AMPICILLIN AND SULBACTAM
- **Generic name:** AMPICILLIN SODIUM AND SULBACTAM SODIUM
- **Active ingredients:** AMPICILLIN SODIUM; SULBACTAM SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** SANDOZ
- **Manufacturer:** Hospira, Inc
- **First approval:** 2006-07-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=065310)
---
*AI Analytics · CC0 1.0*